Global medical beauty company JDBIO Co., Ltd. (CEO Jin-Dong Kim) has announced continuous annual sales growth, led by its expanding presence in international markets.
At Korea’s prestigious Trade Day event, JDBIO was awarded the Export Tower for two consecutive years—achieving $30 million in exports in 2023 and $50 million in 2024—demonstrating its successful global expansion. The company has earned strong brand recognition in key markets such as the United States, Europe, and Russia, achieving solid results through product reliability and trust.
Centered on core product lines including RICHESSE™, Toxin, OneFill™, Exo’One, JADE™, and DEMEI™, JDBIO has consistently proven product performance through ongoing research and development (R&D), solidifying its status as one of Korea’s leading medical beauty companies.
Looking ahead, JDBIO plans to continue strengthening its competitiveness in the global market through innovation and R&D. The company has set a goal to achieve the $70 million Export Tower award in 2025.
Upon receiving the $50 million Export Tower in December, CEO Jin-Dong Kim stated, “Thanks to our advanced technology and the trust of our customers, we have achieved great success in overseas markets, reaching the $50 million export milestone. Moving forward, we aim to further expand into global markets, enhance the competitiveness of our brands, and differentiate ourselves with unique product strategies and new launches.”
Meanwhile, JDBIO is preparing to launch a lineup of competitive new products, with a strategic focus on marketing and sales efforts to ensure their success in global markets.